Home > Insider Trading > Filing (0001209191-14-046450)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1245104	Globeimmune Inc	GBIM	Pharmaceutical Preparations (2834)	841353925

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1013469	W John Littlechild	C/O Healthcare Ventures Llc 47 Thorndike Street, Suite B1-1 Cambridge MA 02141	No	No	Yes	No
1013473	H James Cavanaugh	C/O Healthcare Ventures Llc 47 Thorndike Street, Suite B1-1 Cambridge MA 02141	No	No	Yes	No
1013603	R Harold Werner	C/O Healthcare Ventures Llc 47 Thorndike Street, Suite B1-1 Cambridge MA 02141	No	No	Yes	No
1202615	Healthcare Ventures Vii Lp	47 Thorndike Street Suite B1-1 Cambridge MA 02141	No	No	Yes	No
1262326	Christopher Mirabelli	C/O Healthcare Ventures Llc 47 Thorndike Street, Suite B1-1 Cambridge MA 02141	No	No	Yes	No
1262327	Augustine Lawlor	C/O Healthcare Ventures Llc 47 Thorndike Street, Suite B1-1 Cambridge MA 02141	Yes	No	Yes	No
1330957	Healthcare Partners Vii, L.p.	47 Thorndike Street Suite B1-1 Cambridge MA 02141	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-07-08	80,533	$0.00	80,533	No	4	C	Indirect	By Partnership
Common Stock	Acquisiton	2014-07-08	188,096	$0.00	268,629	No	4	C	Indirect	By Partnership
Common Stock	Acquisiton	2014-07-08	123,574	$0.00	392,203	No	4	C	Indirect	By Partnership
Common Stock	Acquisiton	2014-07-08	2,064	$0.00	394,267	No	4	C	Indirect	By Partnership
Common Stock	Acquisiton	2014-07-08	190,000	$10.00	584,267	No	4	P	Indirect	By Partnership

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By Partnership
No	4	C	Indirect	By Partnership
No	4	C	Indirect	By Partnership
No	4	C	Indirect	By Partnership
No	4	P	Indirect	By Partnership

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Convertible Preferred Stock	Disposition	2014-07-08	2,528,000	$0.00	80,533	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2014-07-08	5,904,335	$0.00	188,096	$0.00
Common Stock	Series C Convertible Preferred Stock	Disposition	2014-07-08	3,879,015	$0.00	123,574	$0.00
Common Stock	Series E Convertible Preferred Stock	Disposition	2014-07-08	64,809	$0.00	2,064	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Effective immediately upon the closing of the issuer's initial public offering of its common stock, each share of convertible preferred stock automatically converted on a 1 for 31.39 basis into shares of common stock of the issuer. Pursuant to the terms of the convertible preferred stock, the conversion of the shares of the preferred stock was done on a certificate by certificate basis with fractional shares paid out to the reporting persons in cash. The convertible preferred stock had no expiration date.
These securities are held of record by HealthCare Ventures VII, L.P. ("HCVVII"). HealthCare Partners VII, L.P. ("HCPVII") is the General Partner of HCVVII. Each of James Cavanaugh, Christopher Mirabelli, Harold Werner, John Littlechild and Augustine Lawlor are general partners of HCPVII and exercise shared voting and investment power with respect to the shares owned by HCVVII. Each of the reporting persons disclaims beneficial ownership of such securities, except to the extent of their proportionate pecuniary interest therein. In addition, Mr. Lawlor is a member of the Board of Directors of the Issuer.
These shares were purchased by HCVVII.